• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者适度饮酒的影响。

Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease.

出版信息

Gut Liver. 2019 May 15;13(3):308-314. doi: 10.5009/gnl18175.

DOI:10.5009/gnl18175
PMID:30400736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6529167/
Abstract

Whether moderate alcohol intake is beneficial remains an unsolved issue. Recent studies have suggested that moderate alcohol consumption is associated with beneficial effects related to the prevention of cardiovascular diseases. Moderate alcohol consumption leads to a higher risk of hepatocellular carcinoma in patients with chronic viral liver diseases. However, the effects of moderate alcohol intake in patients with nonalcoholic fatty liver disease are unclear. In this review, we analyzed, from various perspectives, the effect of moderate alcohol consumption in patients with nonalcoholic fatty liver disease. We reviewed four cohort studies and seven cross-sectional studies. The results showed that moderate alcohol consumption was negatively related to the incidence of nonalcoholic steatohepatitis and liver fibrosis. However, moderate alcohol consumption was positively associated with the incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease. The results of the analysis of the relationship between moderate alcohol consumption and the levels of triglycerides, total cholesterol, high-density lipoprotein, and hypertension were diverse. More clinical data are needed to draw a conclusion about the effects of moderate alcohol consumption in patients with nonalcoholic fatty liver disease.

摘要

适量饮酒是否有益仍然是一个悬而未决的问题。最近的研究表明,适量饮酒与预防心血管疾病的有益作用有关。适量饮酒会增加慢性病毒性肝病患者肝细胞癌的风险。然而,非酒精性脂肪性肝病患者适量饮酒的影响尚不清楚。在这篇综述中,我们从多个角度分析了非酒精性脂肪性肝病患者适量饮酒的效果。我们回顾了四项队列研究和七项横断面研究。结果表明,适量饮酒与非酒精性脂肪性肝炎和肝纤维化的发生率呈负相关。然而,适量饮酒与非酒精性脂肪性肝病患者肝细胞癌的发生率呈正相关。分析适量饮酒与甘油三酯、总胆固醇、高密度脂蛋白和高血压水平之间关系的结果各不相同。需要更多的临床数据来得出关于非酒精性脂肪性肝病患者适量饮酒影响的结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3d/6529167/d80c38dc50e8/gnl-13-308f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3d/6529167/d80c38dc50e8/gnl-13-308f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3d/6529167/d80c38dc50e8/gnl-13-308f1.jpg

相似文献

1
Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者适度饮酒的影响。
Gut Liver. 2019 May 15;13(3):308-314. doi: 10.5009/gnl18175.
2
Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease.荟萃分析:轻度至中度饮酒对进展性非酒精性脂肪性肝病的影响
Aliment Pharmacol Ther. 2023 Apr;57(8):820-836. doi: 10.1111/apt.17388. Epub 2023 Jan 27.
3
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.饮酒和代谢综合征对非酒精性和酒精性脂肪性肝病患者死亡率的影响。
Clin Gastroenterol Hepatol. 2019 Jul;17(8):1625-1633.e1. doi: 10.1016/j.cgh.2018.11.033. Epub 2018 Nov 23.
4
Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease.非酒精性脂肪性肝病男性适度饮酒与颈动脉斑块或颈动脉狭窄
Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21.
5
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.非酒精性脂肪性肝病中适度饮酒是好是坏?一项批判性综述。
Hepatology. 2017 Jun;65(6):2090-2099. doi: 10.1002/hep.29055. Epub 2017 Apr 28.
6
The Effects of Alcohol on Other Chronic Liver Diseases.酒精对其他慢性肝病的影响。
Clin Liver Dis. 2016 Aug;20(3):581-94. doi: 10.1016/j.cld.2016.02.013. Epub 2016 Apr 5.
7
Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease.糖尿病合并非酒精性脂肪性肝病患者的饮酒情况。
Can J Gastroenterol Hepatol. 2017;2017:7927685. doi: 10.1155/2017/7927685. Epub 2017 Nov 1.
8
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions.饮酒与肥胖:酒精性肝病/非酒精性脂肪性肝病的相互作用。
Semin Liver Dis. 2020 May;40(2):154-162. doi: 10.1055/s-0040-1701443. Epub 2020 Feb 18.
9
The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease.非酒精性脂肪肝患者中饮酒与慢性肾脏病的关系。
Scand J Gastroenterol. 2024 Apr;59(4):480-488. doi: 10.1080/00365521.2023.2299304. Epub 2024 Jan 5.
10
Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study.非重度饮酒与弗雷明汉心脏研究中的肝纤维化和非酒精性脂肪性肝炎相关。
Clin Gastroenterol Hepatol. 2023 Oct;21(11):2854-2863.e2. doi: 10.1016/j.cgh.2022.10.039. Epub 2022 Dec 8.

引用本文的文献

1
Misclassification of Alcohol Use Disorder in MASLD and MetALD: Prevalence, Clinical Characteristics, and Outcomes.非酒精性脂肪性肝病和代谢性脂肪性肝病中酒精使用障碍的误诊:患病率、临床特征及转归
Gut Liver. 2025 Jul 25. doi: 10.5009/gnl250072.
2
Machine learning prediction of hepatic steatosis using body composition parameters: A UK Biobank Study.利用身体成分参数进行机器学习预测肝脂肪变性:一项英国生物银行研究。
NPJ Aging. 2024 Jan 9;10(1):4. doi: 10.1038/s41514-023-00127-z.
3
Correspondence on Letter regarding "Waiting for the changes after the adoption of steatotic liver disease".

本文引用的文献

1
Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.在非酒精性脂肪性肝病患者中,适度饮酒与肝组织脂肪变性和脂肪性肝炎改善程度较小相关。
Clin Gastroenterol Hepatol. 2018 Sep;16(9):1511-1520.e5. doi: 10.1016/j.cgh.2018.01.026. Epub 2018 Mar 14.
2
Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease.轻度饮酒有可能抑制非酒精性脂肪性肝病中的肝细胞损伤和肝纤维化。
PLoS One. 2018 Jan 17;13(1):e0191026. doi: 10.1371/journal.pone.0191026. eCollection 2018.
3
关于“等待脂肪性肝病采用后的变化”信件的通信
Clin Mol Hepatol. 2024 Jan;30(1):126-128. doi: 10.3350/cmh.2023.0500. Epub 2023 Nov 28.
4
Dynamic Alterations to Hepatic MicroRNA-29a in Response to Long-Term High-Fat Diet and EtOH Feeding.长期高脂肪饮食和乙醇喂养对肝 microRNA-29a 的动态改变。
Int J Mol Sci. 2023 Sep 26;24(19):14564. doi: 10.3390/ijms241914564.
5
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease.适量饮酒对非酒精性脂肪肝的影响。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S261-S267. doi: 10.3350/cmh.2022.0393. Epub 2022 Dec 22.
6
Exposure to Air Pollution and Survival in Follow-Up after Hepatocellular Carcinoma.肝细胞癌患者接触空气污染与随访期生存情况
Liver Cancer. 2022 Jun 15;11(5):474-482. doi: 10.1159/000525346. eCollection 2022 Sep.
7
Molecular Changes in Relation to Alcohol Consumption and Hepatocellular Carcinoma.与饮酒和肝细胞癌相关的分子变化。
Int J Mol Sci. 2022 Aug 26;23(17):9679. doi: 10.3390/ijms23179679.
8
Effects of moderate ethanol consumption as a function of n-6:n-3 dietary ratio on lipid profile, inflammation, and liver function in mice.适度饮酒对小鼠血脂、炎症和肝功能的影响与饮食中n-6:n-3比例的关系。
Int J Cardiol Cardiovasc Risk Prev. 2022 May 14;14:200132. doi: 10.1016/j.ijcrp.2022.200132. eCollection 2022 Sep.
9
Diet and exercise in NAFLD/NASH: Beyond the obvious.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的饮食和运动:超越显而易见的。
Liver Int. 2021 Oct;41(10):2249-2268. doi: 10.1111/liv.15024. Epub 2021 Aug 21.
10
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease.非酒精性脂肪肝中适量饮酒的影响。
Clin Mol Hepatol. 2020 Oct;26(4):662-669. doi: 10.3350/cmh.2020.0163. Epub 2020 Sep 25.
Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease.
糖尿病合并非酒精性脂肪性肝病患者的饮酒情况。
Can J Gastroenterol Hepatol. 2017;2017:7927685. doi: 10.1155/2017/7927685. Epub 2017 Nov 1.
4
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease.饮酒与代谢综合征的双向影响:进展性脂肪肝的协同因素。
J Hepatol. 2018 Feb;68(2):251-267. doi: 10.1016/j.jhep.2017.11.006. Epub 2017 Nov 4.
5
Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men.适度饮酒和吸烟对中国老年男性非酒精性脂肪性肝病风险的独立及联合影响。
PLoS One. 2017 Jul 20;12(7):e0181497. doi: 10.1371/journal.pone.0181497. eCollection 2017.
6
Moderate alcohol intake induces thermogenic brown/beige adipocyte formation elevating retinoic acid signaling.适度饮酒会诱导产热的棕色/米色脂肪细胞形成,增强视黄酸信号传导。
FASEB J. 2017 Oct;31(10):4612-4622. doi: 10.1096/fj.201700396R. Epub 2017 Jul 5.
7
Hepatitis B virus infection and alcohol consumption.乙型肝炎病毒感染与饮酒
World J Gastroenterol. 2017 Apr 21;23(15):2651-2659. doi: 10.3748/wjg.v23.i15.2651.
8
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.非酒精性脂肪性肝病中适度饮酒是好是坏?一项批判性综述。
Hepatology. 2017 Jun;65(6):2090-2099. doi: 10.1002/hep.29055. Epub 2017 Apr 28.
9
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者一生低至中度饮酒与肝纤维化进展程度较低有关。
Scand J Gastroenterol. 2017 Feb;52(2):159-165. doi: 10.1080/00365521.2016.1239759. Epub 2016 Oct 6.
10
Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic Steatosis.种族因素很重要:饮酒与肝脂肪变性患病率和发病率之间非线性关系的系统评价与荟萃分析
EBioMedicine. 2016 Jun;8:317-330. doi: 10.1016/j.ebiom.2016.04.023. Epub 2016 Apr 20.